AutoImmune Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for AutoImmune Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

AutoImmune Inc.. The Company's principal activities are developing and marketing pharmaceutical products for the treatment of autoimmune and other cell-mediated inflammatory diseases. The products are based on the principles of mucosal tolerance. Mucosal tolerance utilizes the natural immune system mechanisms associated with the gut, nasal passages, lungs and other mucosally lined tissues. The Company presently focused on products for three diseases: rheumatoid arthritis, multiple sclerosis and Type 1 diabetes. It operates in the United States of America. The Company is in the development stage.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report